RISING PHARMA HOLDINGS INC

RISING PHARMA HOLDINGS INC (United States) holds 2 active US FDA Type II Drug Master Files and has DMF or CEP filings on record for 2 active ingredients. 32 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “RISING PHARMA HOLDINGS INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/rising-pharma-holdings-inc

Overview

RISING PHARMA HOLDINGS INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering COLESTIPOL HYDROCHLORIDE (POVIDONE PREMIX); METAXALONE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which RISING PHARMA HOLDINGS INC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

RISING PHARMA HOLDINGS INC holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • COLESTIPOL HYDROCHLORIDE (POVIDONE PREMIX)Active2019-02-21
  • METAXALONEActive2000-10-11

FDA compliance signals

32 FDA enforcement records linked to this company.

  • 4832022-04-08

    Investigations of discrepancies, failures

  • 4832022-04-08

    Absence of Written Procedures

  • 4832022-04-08

    Procedures for sterile drug products

  • warning_letter2019-01-04

    FDA Warning Letter (drug product)

  • 4832017-04-26

    Procedures not in writing, fully followed

  • 4832017-04-26

    Equipment Design, Size and Location

  • 4832017-04-26

    Validation lacking for sterile drug products

  • 4832014-06-06

    Sanitation--buildings not clean, free of infestation

  • 4832010-09-17

    Written record of investigation incomplete

  • 4832010-09-17

    Quality control unit review of records

  • 4832010-09-17

    Failing drug products not rejected

  • 4832010-09-17

    Components withheld from use pending release

  • 4832010-09-17

    SOPs not followed / documented

  • 4832010-09-17

    Procedures To Be in Writing

  • 4832010-09-17

    Expiration date lacking

  • 4832010-09-17

    Rejecting When Specifications Not Met

  • 4832010-09-17

    Manufacturing Instructions and Specifications

  • 4832010-09-17

    Investigations of discrepancies, failures

  • 4832009-06-30

    Validation lacking for sterile drug products

  • 4832009-06-30

    Cleaning / Sanitizing / Maintenance

  • 4832009-06-30

    Calibration/Inspection/Checking not done

  • 4832009-06-30

    Adverse Drug Experience

  • 4832009-06-30

    Cleaning SOPs/instructions

  • 4832009-06-30

    Items to cover on annual reviews

  • 4832009-06-30

    Investigations of discrepancies, failures

  • 4832009-06-30

    Investigations made into any unexplained discrepancy

  • 4832009-06-30

    Reprocessing procedures not written or followed

  • 4832009-06-30

    Approval and review of procedures

  • 4832009-06-30

    Procedures not in writing, fully followed

  • 4832009-06-30

    Testing Each Component for Conformity with Specs

  • 4832009-06-30

    Rejecting When Specifications Not Met

  • 4832009-06-30

    Scientifically sound laboratory controls

For suppliers

Is this RISING PHARMA HOLDINGS INC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.